Bio*One Capital

MedCity Influencers

Stent-based therapy developer TriReme Medical lands $17M

TriReme Medical Inc. completed its $17 million Series D financing round. Bio*One Capital PTE LTD led the financing; current investors Three Arch Partners and Adams Street Partners also contributed “strong support,” according to Singapore-based Bio*One’s parent company EDB Investments PTE LTD. The funding will support TriReme‘s product commercialization and development efforts in Asia, according to […]